<DOC>
	<DOCNO>NCT02655029</DOCNO>
	<brief_summary>The main objective study record , routine clinical practice , patient ' adherence treatment Perindopril/Indapamide/Amlodipine fix dose combination , 4 month treatment .</brief_summary>
	<brief_title>Study Recording Adherence Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination</brief_title>
	<detailed_description>This non-interventional study aim record adherence treatment Perindopril/Indapamide/Amlodipine fix dose combination . In parallel blood pressure level record , well safety tolerability fix dose combination .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Indapamide</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>Male female , ambulatory patient &gt; 18 year old . Clinically diagnose essential arterial hypertension . Under treatment Perindoril/Indapamide/Amlodipine fix dose combination . The patient give his/her write consent inform , inclusion study . Secondary arterial hypertension . Serious end stage disease , severe neuropsychiatric disease , cerebrovascular event serious residual lesion , schedule procedure surgical operation hospital admission . Pregnancy , lactation intention become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>